VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10025391 | HBV | ENSG00000205629.12 | protein_coding | LCMT1 | No | No | 51451 | Q9UIC8 |
TVIS30040648 | HIV | ENSG00000205629.12 | protein_coding | LCMT1 | No | No | 51451 | Q9UIC8 |
TVIS30040649 | HIV | ENSG00000205629.12 | protein_coding | LCMT1 | No | No | 51451 | Q9UIC8 |
TVIS20000728 | HPV | ENSG00000205629.12 | protein_coding | LCMT1 | No | No | 51451 | Q9UIC8 |
TVIS20032311 | HPV | ENSG00000205629.12 | protein_coding | LCMT1 | No | No | 51451 | Q9UIC8 |
TVIS44017875 | HTLV-1 | ENSG00000205629.12 | protein_coding | LCMT1 | No | No | 51451 | Q9UIC8 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | LCMT1 |
---|---|
DrugBank ID | DB00149 |
Drug Name | Leucine |
Target ID | BE0000450 |
UniProt ID | Q9UIC8 |
Regulation Type | |
PubMed IDs | 17139284; 17016423 |
Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. |
Groups | Investigational; Nutraceutical |
Direct Classification | Leucine and derivatives |
SMILES | CC(C)C[C@H](N)C(O)=O |
Pathways | 3-Methylglutaconic Aciduria Type III; 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Demeclocycline Action Pathway; Josamycin Action Pathway; Gentamicin Action Pathway; Lincomycin Action Pathway; Isobutyryl-CoA Dehydrogenase Deficiency; Methacycline Action Pathway; Clarithromycin Action Pathway; Paromomycin Action Pathway; Minocycline Action Pathway; Lymecycline Action Pathway; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency; Glutaminolysis and Cancer; Troleandomycin Action Pathway; Amikacin Action Pathway; Methylmalonic Aciduria; Oxytetracycline Action Pathway; Tetracycline Action Pathway; Spectinomycin Action Pathway; Doxycycline Action Pathway; Telithromycin Action Pathway; Roxithromycin Action Pathway; Tigecycline Action Pathway; Valine, Leucine, and Isoleucine Degradation; Arbekacin Action Pathway; Isovaleric Acidemia; Chloramphenicol Action Pathway |
PharmGKB | PA450197 |
ChEMBL | CHEMBL291962 |